Literature DB >> 21310839

Family history is a risk factor for COPD.

Craig P Hersh1, John E Hokanson2, David A Lynch3, George R Washko4, Barry J Make5, James D Crapo5, Edwin K Silverman6.   

Abstract

BACKGROUND: Studies have shown that family history is a risk factor for COPD, but have not accounted for family history of smoking. Therefore, we sought to identify the effects of family history of smoking and family history of COPD on COPD susceptibility.
METHODS: We compared 821 patients with COPD to 776 control smokers from the Genetic Epidemiology of COPD (COPDGene) Study. Questionnaires captured parental histories of smoking and COPD, as well as childhood environmental tobacco smoke (ETS) exposure. Socioeconomic status was defined by educational achievement.
RESULTS: Parental history of smoking (85.5% case patients, 82.9% control subjects) was more common than parental history of COPD (43.0% case patients, 30.8% control subjects). In a logistic regression model, parental history of COPD (OR, 1.73; P < .0001) and educational level (OR, 0.48 for some college vs no college; P < .0001) were significant predictors of COPD, but parental history of smoking and childhood ETS exposure were not significant. The population-attributable risk from COPD family history was 18.6%. Patients with COPD with a parental history had more severe disease, with lower lung function, worse quality of life, and more frequent exacerbations. There were nonsignificant trends for more severe emphysema and airway disease on quantitative chest CT scans.
CONCLUSIONS: Family history of COPD is a strong risk factor for COPD, independent of family history of smoking, personal lifetime smoking, or childhood ETS exposure. Although further studies are required to identify genetic variants that influence COPD susceptibility, clinicians should question all smokers, especially those with known or suspected COPD, regarding COPD family history.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310839      PMCID: PMC3198493          DOI: 10.1378/chest.10-2761

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  44 in total

1.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

2.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

Review 3.  Socioeconomic status and lung function.

Authors:  Matthew J Hegewald; Robert O Crapo
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

4.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

Authors:  Bipen D Patel; Harvey O Coxson; Sreekumar G Pillai; Alvar G N Agustí; Peter M A Calverley; Claudio F Donner; Barry J Make; Nestor L Müller; Stephen I Rennard; Jørgen Vestbo; Emiel F M Wouters; Melanie P Hiorns; Yasutaka Nakano; Patricia G Camp; Paola V Nasute Fauerbach; Nicholas J Screaton; Edward J Campbell; Wayne H Anderson; Peter D Paré; Robert D Levy; Stephen L Lake; Edwin K Silverman; David A Lomas
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

5.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Authors:  Rayjean J Hung; James D McKay; Valerie Gaborieau; Paolo Boffetta; Mia Hashibe; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Chu Chen; Gary Goodman; John K Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; John McLaughlin; Geoffrey Liu; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Jakob Linseisen; Françoise Clavel-Chapelon; Paolo Vineis; H Bas Bueno-de-Mesquita; Eiliv Lund; Carmen Martinez; Sheila Bingham; Torgny Rasmuson; Pierre Hainaut; Elio Riboli; Wolfgang Ahrens; Simone Benhamou; Pagona Lagiou; Dimitrios Trichopoulos; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Gary Macfarlane; Renato Talamini; Lorenzo Simonato; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

7.  Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.

Authors:  P-O Bridevaux; M W Gerbase; N M Probst-Hensch; C Schindler; J-M Gaspoz; T Rochat
Journal:  Thorax       Date:  2008-05-27       Impact factor: 9.139

8.  Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.

Authors:  Nina P Paynter; Daniel I Chasman; Julie E Buring; Dov Shiffman; Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391

9.  A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.

Authors:  Sreekumar G Pillai; Dongliang Ge; Guohua Zhu; Xiangyang Kong; Kevin V Shianna; Anna C Need; Sheng Feng; Craig P Hersh; Per Bakke; Amund Gulsvik; Andreas Ruppert; Karin C Lødrup Carlsen; Allen Roses; Wayne Anderson; Stephen I Rennard; David A Lomas; Edwin K Silverman; David B Goldstein
Journal:  PLoS Genet       Date:  2009-03-20       Impact factor: 5.917

10.  Genome-wide and candidate gene association study of cigarette smoking behaviors.

Authors:  Neil Caporaso; Fangyi Gu; Nilanjan Chatterjee; Jin Sheng-Chih; Kai Yu; Meredith Yeager; Constance Chen; Kevin Jacobs; William Wheeler; Maria Teresa Landi; Regina G Ziegler; David J Hunter; Stephen Chanock; Susan Hankinson; Peter Kraft; Andrew W Bergen
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more
  25 in total

1.  Sinogram Affirmed Iterative Reconstruction (SAFIRE) versus weighted filtered back projection (WFBP) effects on quantitative measure in the COPDGene 2 test object.

Authors:  J P Sieren; E A Hoffman; M K Fuld; K S Chan; J Guo; J D Newell
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

2.  Digital Family History Data Mining with Neural Networks: A Pilot Study.

Authors:  Robert Hoyt; Steven Linnville; Stephen Thaler; Jeffrey Moore
Journal:  Perspect Health Inf Manag       Date:  2016-01-01

Review 3.  Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update.

Authors:  Mohamed Sabeer Abdool-Gaffar; Gregory Calligaro; Michelle Lianne Wong; Clifford Smith; Umesh Gangaram Lalloo; Coenraad Frederik Nicolaas Koegelenberg; Keertan Dheda; Brian William Allwood; Akhter Goolam-Mahomed; Richard Nellis van Zyl-Smit
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

4.  Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.

Authors:  Mehrdad Arjomandi; Siyang Zeng; Igor Barjaktarevic; R Graham Barr; Eugene R Bleecker; Russell P Bowler; Russell G Buhr; Gerard J Criner; Alejandro P Comellas; Christopher B Cooper; David J Couper; Jeffrey L Curtis; Mark T Dransfield; MeiLan K Han; Nadia N Hansel; Eric A Hoffman; Robert J Kaner; Richard E Kanner; Jerry A Krishnan; Robert Paine; Stephen P Peters; Stephen I Rennard; Prescott G Woodruff
Journal:  Eur Respir J       Date:  2019-10-31       Impact factor: 16.671

Review 5.  Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.

Authors:  Caiyang Liu; Ran Ran; Xiaoliang Li; Gaohua Liu; Xiaoyang Xie; Ji Li
Journal:  Can Respir J       Date:  2022-06-09       Impact factor: 2.130

6.  Paraoxonase-1 gene in patients with chronic obstructive pulmonary disease investigation Q192R and L55M polymorphisms.

Authors:  Şükrü Gürbüz; Mustafa Yıldız; Murat Kara; Kürşat Kargün; Mehtap Gürger; Metin Ateşçelik; Ömer Doğan Alataş
Journal:  World J Emerg Med       Date:  2015

7.  Familial transmission of chronic obstructive pulmonary disease in adoptees: a Swedish nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  BMJ Open       Date:  2015-04-13       Impact factor: 2.692

8.  Pulmonary function tests and impulse oscillometry in severe chronic obstructive pulmonary disease patients' offspring.

Authors:  Babak Amra; Victoria Beigi Borougeni; Mohammad Golshan; Forogh Soltaninejad
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

9.  Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD.

Authors:  Craig P Hersh; George R Washko; Raúl San José Estépar; Sharon Lutz; Paul J Friedman; MeiLan K Han; John E Hokanson; Philip F Judy; David A Lynch; Barry J Make; Nathaniel Marchetti; John D Newell; Frank C Sciurba; James D Crapo; Edwin K Silverman
Journal:  Respir Res       Date:  2013-04-08

10.  Prediction of acute respiratory disease in current and former smokers with and without COPD.

Authors:  Russell P Bowler; Victor Kim; Elizabeth Regan; André A A Williams; Stephanie A Santorico; Barry J Make; David A Lynch; John E Hokanson; George R Washko; Peter Bercz; Xavier Soler; Nathaniel Marchetti; Gerard J Criner; Joe Ramsdell; MeiLan K Han; Dawn Demeo; Antonio Anzueto; Alejandro Comellas; James D Crapo; Mark Dransfield; J Michael Wells; Craig P Hersh; Neil MacIntyre; Fernando Martinez; Hrudaya P Nath; Dennis Niewoehner; Frank Sciurba; Amir Sharafkhaneh; Edwin K Silverman; Edwin J R van Beek; Carla Wilson; Christine Wendt; Robert A Wise
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.